| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2100003 | 重组抗RANKL全人源单克隆抗体注射液 | denosumab | Injection | Biological Products(3.3) | New Drug Application | 2021-01-06 | 上海翰森生物医药科技有限公司 | Shanghai Hansoh BioMedical Co Ltd | In Review | 2021-01-06 | view |
| CXSL2000036 | HS-20090注射液 | HS-20090 | Injection | Biological Products(2) | New Drug Application | 2020-02-26 | 上海翰森生物医药科技有限公司 | Shanghai Hansoh BioMedical Co Ltd;Jiangsu Hansoh Pharmaceutical Group Co Ltd | In Review | 2020-02-25 | view |